Mode
Text Size
Log in / Sign up
N/A N=6 Single-blind Treatment

Apraxia of Speech: Comparison of EPG Treatment (Tx) and Sound Production Treatment (SPT)

Apraxia of Speech · Aphasia, Acquired · Speech Disorders

Enrolled (actual)
6
Serious AEs
0.0%
Results posted
Nov 2021
Primary outcome: Primary: Speech Production: Percent Change in Treated Items Immediately Post Treatment — 59; 66 % change

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
EPG Tx (Device); SPT (Behavioral)
Age
Adult, Older Adult · 21+ yrs
Sex
All
Sponsor
VA Office of Research and Development
Primary completion
Feb 2019

Outcome Measures

OutcomeResultp-value
PRIMARY
Speech Production: Percent Change in Treated Items Immediately Post Treatment
59; 66
SECONDARY
Speech Production: Percent Change in Untreated Items (Related Items) Immediately Post Treatment
5; 50
SECONDARY
Speech Production: Percent Change for Treated Items After the Completion of Treatment
43; 61
SECONDARY
Functional Communication Skills: T-Score
43.0; 46.0
SECONDARY
Speech Intelligibility: Percentage
40.0; 50.0

Summary

The purpose of the proposed research is to examine the effects of two treatment approaches on speech production involving speakers with chronic apraxia of speech (AOS) and aphasia. The planned investigation is designed to examine the acquisition, maintenance and generalization effects of each treatment. One approach, electropalatography (EPG) uses visual biofeedback in conjunction with articulatory-kinematic treatment and the other approach, sound production treatment (SPT) is one of the most systematically studied articulatory-kinematic treatments for AOS.

Eligibility Criteria

Inclusion Criteria

  • Veterans or non Veterans with apraxia of speech who reside in the Salt Lake City region (commutable),
  • 6 months or more post stroke or other focal brain injury, no other neurological conditions
  • native English speakers, hearing adequate for experimental task (e.g., pass puretone screening at 35dB at 500, 1K, 2K Hz or adequate aided hearing)
  • non linguistic cognition within normal limits

Exclusion Criteria

  • less than 6 months post stroke
  • insufficient hearing, insufficient non linguistic cognitive skills
  • neurological conditions other than stroke
  • unable to attend treatment in the Salt Lake City vicinity
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02554513). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search